Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE) announced fourth-quarter results Jan. 12 of $164.87 million. That’s a 29% ...

Loan originations were up for the full year totaling $139.4 billion, an increase from $108.3 billion in 2023. Purchase ...

For the three months and full-year ended December 31, 2024, from continuing operations:Revenues of $697.0 million for the fourth quarter, ...

Total Revenues of $491.7 Million, Marking Another Year of Record GrowthFull Year 2024 Total Revenues Grew 23.5% YoY, Driven by ...

Reiterates 2025 guidance, with the number of patients on LUMRYZ expected to increase to 3,300-3,500 by year-end, generating $240-$260 million in net product revenue and cash flow of $20-40 million -- ...

Which stock has Warren Buffett bought more than any other in recent years? That's an easy question. The answer is clearly ...

The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the fiscal ...

Year over year (YoY) is a way of slicing data to compare two different points in time. Read on to understand how it's used ...

EOG Resources beat fourth-quarter profit estimates on higher production, but shares fell 4.1% on Friday as the company ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...

Regardless of the fine points about where it will be next year, one thing to be fairly confident about is that Amazon has a ...